Orchid Cellmark Inc Watch

from 8-K 94 pages Agreement and Plan of Merger Dated as of April 5, 2011 Among Laboratory Corporation of America Holdings, Ocm Acquisition Corp. and Orchid Cellmark Inc

from 8-K 4 pages (A) an Agreement Between Orchid Biosciences Europe Limited (The “Seller”), Tepnel Diagnostics Limited (The “Purchaser”), Orchid Biosciences, Inc (“Orchid Inc”) and Tepnel Life Sciences PLC (“Tepnel PLC”) (As Amended by a Letter Dated 9 December 2003) Under Which the Purchaser Agreed to Purchase and the Seller Agreed to Sell the Goodwill and Assets Comprised in the Diagnostics Business as Set Out in That Agreement (The “Uk Agreement”); and (B) an Agreement Between Lifecodes Corporation (“Lifecodes”), the Purchaser, Orchid Inc and Tepnel PLC Under Which the Purchaser Agreed to Purchase and the Seller Agreed to Sell All of the Shares in Orchid Diagnostics Europe Bvba (The “Belgian Agreement”). 1. Revocation of Termination Notices

from 8-K 2 pages Dear Sirs, Sale of the Diagnostics Business of Orchid Biosciences Europe Limited

from 8-K 6 pages Amendment, Waiver and Revocation of Termination of Asset Purchase Agreement

from SC 13G 1 page Statement of Control Person

from SC 13G 1 page Statement of Control Person

from 8-K >50 pages Agreement and Plan of Merger

from S-1/A >50 pages Agreement & Plan of Merger